Joining this announcement was news of a second unveiling: Novavax is planning to ship vaccines to the European Union in late 2021. Reported by Reuters, the deal will see 200 million doses of Novavax's Covid-19 shot making their way to Europe. The doses reportedly were meant to make their way over earlier, but a supply chain issue prevented this. Now, the shipment has seen approval, and will be making its way overseas alongside shipments of Pfizer (NYSE: